Unknown

Dataset Information

0

LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8+ T cells for improving anti-PD-1 antibody therapy.


ABSTRACT: Anti-PD-1 antibody therapy has achieved success in tumor treatment; however, the duration of its clinical benefits are typically short. The functional state of intratumoral CD8+ T cells substantially affects the efficacy of anti-PD-1 antibody therapy. Understanding how intratumoral CD8+ T cells change will contribute to the improvement in anti-PD-1 antibody therapy. In this study, we found that tumor growth was not arrested after the late administration of anti-PD-1 antibody and that the antitumor function of CD8+ T cells decreased with tumor progression. The results of the RNA sequencing of CD8+ T cells infiltrating the tumor site on days 7 and 14 showed that the cell adhesion molecule Lymphocyte Function-associated Antigen-1 (LFA-1) participates in regulating the antitumor function of CD8+ T cells and that decreased LFA-1 expression in intratumoral CD8+ T cells is associated with tumor progression. By analyzing the Gene Expression Omnibus (GEO) database and our results, we found that the antitumor function of intratumoral CD8+ T cells with high LFA-1 expression was stronger. The formation of immune synapses is impaired in Itgal-si CD8+ T cells, resulting in decreased anti-tumor function. LFA-1 expression in intratumoral CD8+ T cells is regulated by the IL-2/STAT5 pathway. The combination of IL-2 and anti-PD-1 antibody effectively enhanced LFA-1 expression and the antitumor function of intratumoral CD8+ T cells. The adoptive transfer of OT-1 T cells overexpressing LFA-1, STAT5A, or STAT5B resulted in higher antitumor function, deferred tumor growth, and prolonged survival. These findings indicate that LFA-1-mediated immune synapse acts as a regulator of the antitumor function of intratumoral CD8+ T cells, which can be applied to improve anti-PD-1 antibody therapy.

SUBMITTER: Shan J 

PROVIDER: S-EPMC10730141 | biostudies-literature | 2024

REPOSITORIES: biostudies-literature

altmetric image

Publications

LFA-1 regulated by IL-2/STAT5 pathway boosts antitumor function of intratumoral CD8<sup>+</sup> T cells for improving anti-PD-1 antibody therapy.

Shan Jiqi J   Jing Wei W   Ping Yu Y   Shen Chunyi C   Han Dong D   Liu Fengsen F   Liu Yaqing Y   Li Congcong C   Zhang Yi Y  

Oncoimmunology 20231214 1


Anti-PD-1 antibody therapy has achieved success in tumor treatment; however, the duration of its clinical benefits are typically short. The functional state of intratumoral CD8<sup>+</sup> T cells substantially affects the efficacy of anti-PD-1 antibody therapy. Understanding how intratumoral CD8<sup>+</sup> T cells change will contribute to the improvement in anti-PD-1 antibody therapy. In this study, we found that tumor growth was not arrested after the late administration of anti-PD-1 antibod  ...[more]

Similar Datasets

2025-05-01 | GSE249184 | GEO
| PRJNA1047612 | ENA
| S-EPMC8102368 | biostudies-literature
| S-EPMC10673920 | biostudies-literature
| S-EPMC9596411 | biostudies-literature
| S-EPMC5754226 | biostudies-literature
| S-EPMC4839350 | biostudies-literature
| S-EPMC11924119 | biostudies-literature
| S-EPMC11583082 | biostudies-literature
| S-EPMC8407215 | biostudies-literature